Abcam (ABCM) Pre-Tax Income : $1.5 Mil (TTM As of Jun. 2023)

View and export this data going back to 2010. Start your Free Trial

What is Abcam Pre-Tax Income?

Pretax income is the income that a company earns before paying income taxes. Abcam's pretax income for the six months ended in Jun. 2023 was $29.5 Mil. Its pretax income for the trailing twelve months (TTM) ended in Jun. 2023 was $1.5 Mil. Abcam's pretax margin was 11.52%.

During the past 13 years, Abcam's highest Pretax Margin was 35.43%. The lowest was -4.31%. And the median was 28.04%.

Abcam Pre-Tax Income Historical Data

The historical data trend for Abcam's Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Abcam Pre-Tax Income Chart

Abcam Annual Data

Trend

Jun12

Jun13

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Dec22

Pre-Tax Income

Get a 7-Day Free Trial

66.45

91.89

71.48

10.51

-19.00

Abcam Semi-Annual Data
	Jun13	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Jun22	Dec22	Jun23
Pre-Tax Income	Get a 7-Day Free Trial															18.55	12.90	9.11	-28.02	29.55

Competitive Comparison of Abcam's Pre-Tax Income

For the Biotechnology subindustry, Abcam's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Abcam's Pre-Tax Income Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Abcam's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where Abcam's Pre-Tax Income falls into.

Abcam Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

Abcam's Pretax Income for the fiscal year that ended in Dec. 2022 is calculated as

Pretax Income	=	Operating Income	+	Non Operating Income	+	Interest Expense	+	Interest Income	+	Other
	=	-12.302	+	0	+	-6.577	+	0.487	+	-0.609
	=	-19.0

Abcam's Pretax Income for the quarter that ended in Jun. 2023 is calculated as

Pretax Income	=	Operating Income	+	Non Operating Income	+	Interest Expense	+	Interest Income	+	Other
	=	35.227	+	0	+	-6.566	+	0.884	+	3.5527136788005E-15
	=	29.5

Pre-Tax Income for the trailing twelve months (TTM) ended in Jun. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was $1.5 Mil.

Abcam (NAS:ABCM) Pre-Tax Income Explanation

Abcam's Pretax Margin for the quarter that ended in Jun. 2023 is calculated as

Pretax Margin	=	Pretax Income	/	Revenue
	=	29.545	/	256.566
	=	11.52%

During the past 13 years, Abcam's highest Pretax Margin was 35.43%. The lowest was -4.31%. And the median was 28.04%.

Abcam Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of Abcam's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.

Abcam (ABCM) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Abcam PLC (NAS:ABCM) » Definitions » Pre-Tax Income

Comparable Companies

Traded in Other Exchanges

N/A

Address

Discovery Drive, Cambridge Biomedical Campus, Cambridge, GBR, CB2 0AX

Website

https://www.abcam.com

Abcam PLC is a biotechnology company that develops and provides antibodies to life science research and clinical communities. The company's products allow research into the role of signaling and regulatory molecules and proteins in biological pathways. Such research ultimately leads to treatments for diseases such as cancer and immune deficiency disorders. Abcam's focused on broadening its product range, improving speed to market, and accessing underpenetrated consumer groups in its markets. The company also selectively pursues partnerships and acquisitions.